TJM Labs reports three funding rounds and acquisitions

TJM Labs announced $100 million raised across three rounds: a $10 million Series A, $15 million Series A-1 and $75 million Series B. The Series B was led by Elephant with participation from Arthur Ventures and Updata Partners. TJM also reported completed acquisitions of EncoreRx and Pharmesol.